Apiam Animal Health Reports Mixed H1 FY25 Results Amid Revenue Growth

An announcement from Apiam Animal Health Ltd. ( (AU:AHX) ) is now available.

Apiam Animal Health Ltd. reported its H1 FY25 financial results, showing a slight increase in revenue by 1.7% to $106.2 million compared to the previous corresponding period. Despite this, the company experienced a significant decline in net profit after tax (NPAT), reporting a loss of $1.5 million, a 145.9% decrease from the previous period. The underlying NPATA also fell by 15.5% to $3.9 million, and the underlying EBITDA decreased by 3.6% to $10.8 million. The interim dividend remained consistent with the prior period at 1.0 cps. These results indicate challenges in maintaining profitability despite revenue growth, which may impact the company’s operational strategies and stakeholder confidence.

More about Apiam Animal Health Ltd.

Apiam Animal Health Ltd. operates in the veterinary services industry, focusing on providing animal health services and products. The company primarily serves the livestock and companion animal markets, offering a range of veterinary services, products, and technologies to enhance animal health and productivity.

YTD Price Performance: 3.70%

Average Trading Volume: 53,024

Technical Sentiment Consensus Rating: Hold

Current Market Cap: A$76.66M

Find detailed analytics on AHX stock on TipRanks’ Stock Analysis page.